Impact of SGLT-2 Inhibitor Use on Atrial Fibrillation Incidence Following Heart Failure Hospitalization

被引：0
|
作者：
Fretz, Thomas
Tanawuttiwat, Tanyanan
Ilonze, Onyedika
Das, Mithilesh
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4138611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4138611
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Heart failure hospitalization with SGLT-2 inhibitors: a systematic review and meta-analysis of randomized controlled and observational studies
    Singh, Awadhesh Kumar
    Singh, Ritu
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (04) : 299 - 308
  • [42] How Do SGLT-2 Inhibitors Work to Prevent Heart Failure?
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2020, 8 (01) : 67 - 69
  • [43] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Garla, Vishnu Vardhan
    Butler, Javed
    Lien, Lillian F.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (06)
  • [44] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Vishnu Vardhan Garla
    Javed Butler
    Lillian F. Lien
    Current Cardiology Reports, 2021, 23
  • [45] SGLT2 INHIBITOR USE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PROPENSITY SCORE MATCHED (PSM) ANALYSIS
    Anuforo, Anderson C.
    Rawlley, Bharat
    Diez, Armando Pichs
    Menezes, Sherna B.
    Ngembus, Ngonack Joan
    Draytsel, Dan
    Palanivel, Kavipriya Kovai
    Ugoala, Onyinye Sylvia
    Ebubechukwu, Ugochukwu Jerome
    Paulraj, Shweta
    Charlamb, Mark J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 51 - 51
  • [46] Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril
    Wagner, M
    Rindress, D
    Desjardins, B
    Meilleur, MC
    Ducharme, A
    Tardif, JC
    AMERICAN HEART JOURNAL, 2005, 150 (05) : 985.e1 - 985.e8
  • [47] The impact of heart failure on the incidence of stroke in patients with atrial fibrillation: the Fushimi AF Registry
    Iguchi, M.
    Tezuka, Y.
    Masunaga, N.
    Ishii, M.
    Esato, M.
    Chun, Y.
    Wada, H.
    Hasegawa, K.
    Ogawa, H.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 925 - 925
  • [48] Use of SGLT-2 inhibitor in COVID-19: A cautionary tale
    Yousaf, Zohaib
    Munir, Waqar
    Hammamy, Riyadh Ali Mohammed
    MEDCOMM, 2021, 2 (01): : 114 - 116
  • [49] Kidney and heart failure outcomes associated with SGLT2 inhibitor use
    Van der Aart-van der Beek, Annemarie B.
    de Boer, Rudolf A.
    Heerspink, Hiddo J. L.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (05) : 294 - 306
  • [50] Kidney and heart failure outcomes associated with SGLT2 inhibitor use
    Annemarie B. van der Aart-van der Beek
    Rudolf A. de Boer
    Hiddo J. L. Heerspink
    Nature Reviews Nephrology, 2022, 18 : 294 - 306
12345